Diligence memo · auto-generated · as of July 2, 2026

Music Audience Exchange, Inc.

Music Audience Exchange, Inc. looks fair against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Music Audience Exchange, Inc. operates in Media & Content, based in FRISCO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Music Audience Exchange, Inc. has raised $13M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.0M on 2017-02-14.

Most recent recorded round closed around 2022-10-11.

Valuation (modeled)modeled

Provath models Music Audience Exchange, Inc. at approximately $28M (range $5.0M–$90M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.75× the median modeled value of Series A Media & Content companies in 2022–2024 (58 peers) — value vs value, same stage and era. Within the normal band (75% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 44 months.

Last raise 3.7 yr ago; this sector typically re-raises about every 12 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round was 1.5× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 87% of Media & Content peers (1052 compared).

Modeled value ranks above 69% of those peers.

Closest niche peers: Arcturus Studios Holdings, Inc., Healing Humanity Productions, Inc., Midnight VSM Studio Inc., B&J Studios Inc., Strimmerz Media, Inc..

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.